Product Information

ATAZANAVIR SULFATE 300 MG CAP is a generic product labeled by Laurus Labs Limited, priced at $1.6552 per EA under NDC 42385092230. Its NADAC has been published 215 times since Mar 16, 2022.

FDA first approved this application on Apr 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATAZANAVIR SULFATE 300 MG CAP

Atazanavir
$1.6552per EA

Strength

300 mg/1

NDC

42385092230

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ATAZANAVIR SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212579

FDA Approved

4/30/2021

TE Code

AB

On Market Since

4/30/2021

Pharmacological Classes

Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inhibitors
UGT1A1 Inhibitors

Price Statistics

The NADAC for ATAZANAVIR SULFATE 300 MG CAP has been published 215 times since Mar 16, 2022, and over the history we have for it it has declined 72.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6552 per EA
All-time high$5.9101 (May 11, 2022)
All-time low$1.6552 (Nov 18, 2026)
52-week high$2.7319
52-week low$1.6552
Median price$3.3003
Average price$3.0911
Largest weekly change+41.4% (Oct 23, 2024)
Weeks tracked215
Tracking sinceMar 16, 2022

Price History

1W

-0.3%

1M

-25.7%

3M

-28.3%

6M

-38.5%

1Y

-40.7%

3Y

-52.5%

5Y

N/A

All

-72.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATAZANAVIR SULFATE 300 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 300 MG CAP, manufactured by Laurus Labs Limited, is $1.6552 per EA (NDC 42385092230), effective Nov 18, 2026.

How has the price of ATAZANAVIR SULFATE 300 MG CAP changed over time?

Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has declined 72.0%. It has been tracked across 215 weekly CMS publications since Mar 16, 2022.

What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 300 MG CAP?

Since Mar 16, 2022, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has ranged from a low of $1.6552 (Nov 18, 2026) to a high of $5.9101 (May 11, 2022), with a median of $3.3003 per EA.

Are there cheaper alternatives to ATAZANAVIR SULFATE 300 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATAZANAVIR SULFATE 300 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures ATAZANAVIR SULFATE 300 MG CAP?

ATAZANAVIR SULFATE 300 MG CAP (NDC 42385092230) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.